SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,215.00    -16.00 (-1.30%)
Bid:
1,215.00
Ask:
1,248.00
Spread: 33.00 (2.716%)
Market Cap: £847.40m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
13th Mar 20254:17 pmRNSStandard form for notification of major holdings
28th Feb 20259:57 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInterim Results
6th Feb 20259:24 amRNSStandard form for notification of major holdings
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 20257:00 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirector/PDMR Shareholding
31st Dec 202410:52 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
26th Nov 20241:59 pmRNSGrant of Options & PDMR Dealing
21st Nov 20244:05 pmRNSStandard form for notification of major holdings
20th Nov 202412:51 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement and Trading Update
4th Nov 20249:18 amRNSStandard form for notification of major holdings
31st Oct 202411:35 amRNSExercise of Options and Total Voting Rights
30th Oct 20244:11 pmRNSStandard form for notification of major holdings
21st Oct 202410:42 amRNSPosting of Annual Report and Notice of AGM
16th Oct 202412:14 pmRNSStandard form for notification of major holdings
14th Oct 20242:34 pmRNSnotification of major holdings
11th Oct 20245:28 pmRNSHolding(s) in Company
4th Oct 20245:11 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
3rd Oct 20247:00 amRNSNotification of major holdings
1st Oct 20247:00 amRNSTotal Voting Rights
26th Sep 20247:00 amRNSFinal results for the year ended 30 June 2024
2nd Sep 20242:45 pmRNSTotal Voting Rights
31st Jul 20247:00 amRNSTotal Voting Rights
30th Jul 20249:42 amRNSHolding(s) in Company
25th Jul 20247:00 amRNSTrading Statement
12th Jul 20247:00 amRNSBlock Listing Interim Review
11th Jul 20241:55 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSExercise of Options and Total Voting Rights
27th Jun 20242:53 pmRNSDirector/PDMR Shareholding
24th Jun 20244:48 pmRNSPDMR Dealing
18th Jun 20241:35 pmRNSDirectorate Change
31st May 20247:00 amRNSTotal Voting Rights
23rd May 20247:12 amRNSResponse to CMA announcement
21st May 20247:00 amRNSDisposal of non-core operations
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights
29th Jan 20243:41 pmRNSPDMR Dealing
25th Jan 20247:00 amRNSHalf year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.